These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray. Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449 [TBL] [Abstract][Full Text] [Related]
3. Integrated immunohistochemical and molecular analysis improves diagnosis of high-grade carcinoma in the urinary bladder of patients with prior radiation therapy for prostate cancer. Chan E; Garg K; Stohr BA Mod Pathol; 2020 Sep; 33(9):1802-1810. PubMed ID: 32313185 [TBL] [Abstract][Full Text] [Related]
4. Clinical utility of immunohistochemistry in the diagnoses of urinary bladder neoplasia. Hodges KB; Lopez-Beltran A; Emerson RE; Montironi R; Cheng L Appl Immunohistochem Mol Morphol; 2010 Oct; 18(5):401-10. PubMed ID: 20505509 [TBL] [Abstract][Full Text] [Related]
5. Morphological and Immunohistochemical Biomarkers in Distinguishing Prostate Carcinoma and Urothelial Carcinoma: A Comprehensive Review. Sanguedolce F; Russo D; Mancini V; Selvaggio O; Calò B; Carrieri G; Cormio L Int J Surg Pathol; 2019 Apr; 27(2):120-133. PubMed ID: 30509113 [TBL] [Abstract][Full Text] [Related]
6. Pseudopapillary features in prostatic adenocarcinoma mimicking urothelial carcinoma: a diagnostic pitfall. Gordetsky J; Epstein JI Am J Surg Pathol; 2014 Jul; 38(7):941-5. PubMed ID: 24503758 [TBL] [Abstract][Full Text] [Related]
7. Plasmacytoid/diffuse urothelial carcinoma: a single-institution immunohistochemical and molecular study of 69 patients. Perrino CM; Eble J; Kao CS; Whaley RD; Cheng L; Idrees M; Hashemi-Sadraei N; Monn MF; Kaimakliotis HZ; Bandali E; Grignon D Hum Pathol; 2019 Aug; 90():27-36. PubMed ID: 31054897 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical evaluation of novel and traditional markers associated with urothelial differentiation in a spectrum of variants of urothelial carcinoma of the urinary bladder. Paner GP; Annaiah C; Gulmann C; Rao P; Ro JY; Hansel DE; Shen SS; Lopez-Beltran A; Aron M; Luthringer DJ; De Peralta-Venturina M; Cho Y; Amin MB Hum Pathol; 2014 Jul; 45(7):1473-82. PubMed ID: 24780825 [TBL] [Abstract][Full Text] [Related]
9. Poorly differentiated adenocarcinomas of prostate versus high-grade urothelial carcinoma of the bladder: a diagnostic dilemma with immunohistochemical evaluation of 2 cases. Martínez-Rodríguez M; Ramos D; Soriano P; Subramaniam M; Navarro S; Llombart-Bosch A Int J Surg Pathol; 2007 Apr; 15(2):213-8. PubMed ID: 17478786 [TBL] [Abstract][Full Text] [Related]
10. Florid von Brunn nests mimicking urothelial carcinoma: a morphologic and immunohistochemical comparison to the nested variant of urothelial carcinoma. Volmar KE; Chan TY; De Marzo AM; Epstein JI Am J Surg Pathol; 2003 Sep; 27(9):1243-52. PubMed ID: 12960809 [TBL] [Abstract][Full Text] [Related]
11. GATA3 expression in paragangliomas: a pitfall potentially leading to misdiagnosis of urothelial carcinoma. So JS; Epstein JI Mod Pathol; 2013 Oct; 26(10):1365-70. PubMed ID: 23599157 [TBL] [Abstract][Full Text] [Related]
13. GATA3 expression in sarcomatoid urothelial carcinoma of the bladder. Fatima N; Osunkoya AO Hum Pathol; 2014 Aug; 45(8):1625-9. PubMed ID: 24824028 [TBL] [Abstract][Full Text] [Related]
14. S100P as a Marker for Urothelial Histogenesis: A Critical Review and Comparison With Novel and Traditional Urothelial Immunohistochemical Markers. Suryavanshi M; Sanz-Ortega J; Sirohi D; Divatia MK; Ohe C; Zampini C; Luthringer D; Smith SC; Amin MB Adv Anat Pathol; 2017 May; 24(3):151-160. PubMed ID: 28398953 [TBL] [Abstract][Full Text] [Related]
15. Serous Carcinoma Mimicking Primary Urothelial Carcinoma on Clinical Evaluation and Pathology: A Potential Diagnostic Pitfall. Mirsadraei L; Hodkoff A; Jones K; Shabaik A; Kader AK; Saenz CC; Montironi R; Tacha DE; Fadare O; Hansel DE Arch Pathol Lab Med; 2018 Feb; 142(2):168-177. PubMed ID: 28795841 [TBL] [Abstract][Full Text] [Related]
16. Urothelial carcinoma of the urinary bladder with a component of acinar/tubular type differentiation simulating prostatic adenocarcinoma. Huang Q; Chu PG; Lau SK; Weiss LM Hum Pathol; 2004 Jun; 35(6):769-73. PubMed ID: 15188146 [TBL] [Abstract][Full Text] [Related]
17. Clear cell urothelial carcinoma of the urinary bladder: a case report and review of the literature. Knez VM; Barrow W; Lucia MS; Wilson S; La Rosa FG J Med Case Rep; 2014 Aug; 8():275. PubMed ID: 25124389 [TBL] [Abstract][Full Text] [Related]
18. Urothelial carcinoma in situ: diagnostic update. McKenney JK Pathology; 2021 Jan; 53(1):86-95. PubMed ID: 33234229 [TBL] [Abstract][Full Text] [Related]
19. Nuclear p53 overexpression in bladder, prostate, and renal carcinomas. Sinik Z; Alkibay T; Ataoglu O; Biri H; Sözen S; Deniz N; Karaoglan U; Bozkirli I Int J Urol; 1997 Nov; 4(6):546-51. PubMed ID: 9477181 [TBL] [Abstract][Full Text] [Related]
20. Tissue polypeptide antigen and carcinoembryonic antigen lack diagnostic accuracy in urothelial carcinoma. Stefanović V; Mitić-Zlatković M; Ignjatović I; Vlajković M; Sćepović Z Int Urol Nephrol; 1999; 31(4):443-9. PubMed ID: 10668938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]